Cancer Enzymes Found in Zebrafish Study
Posted on: Wednesday, 24 December 2008, 14:30 CST
A study of zebrafish has revealed ways to potentially slow or prevent the onset of cancerous tumors, the Huntsman Cancer Institute in Utah says.
Using zebrafish that share genetics similar to humans, researchers discovered two enzymes that, when combined, could be involved in the earliest stages of cancer, the Salt Lake City-based Institute announced Wednesday.
Genetically manipulating the enzymes could lead to therapies that target tumors in their earliest stage, said David Jones, a senior director at Huntsman.
We could conceivably reactivate a completely normal gene in a tumor cell -- a gene that could prevent the growth of a tumor if reactivated,
Jones said.
The enzymes appear to trigger an on-and-off switch
for genes that could could cancer and numerous other diseases and birth defects, said the research published in the Dec. 26 issue of Cell.
Source: United Press International
Related Articles
- Anti-Cancer Enzyme Linked With Body Mass
- CuraGen and TopoTarget Announce Initiation of NCI-Sponsored Phase II Trial of PXD101 for Ovarian Cancer
- CuraGen and TopoTarget Announce Initiation of Phase I/II Trial of PXD101 for Hepatocellular Cancer
- CuraGen and TopoTarget Announce Initiation of NCI-Sponsored Phase I Clinical Trial of PXD101 and Cis-Retinoic Acid
- CuraGen and TopoTarget Announce Initiation of NCI-Sponsored Phase II Clinical Trial With PXD101 for Acute Myelogenous Leukemia
- CuraGen and TopoTarget Present New Preclinical Data on PXD101 at the AACR 97th Annual Meeting
- CuraGen and TopoTarget Announce Initiation of First NCI-Sponsored Clinical Trial With PXD101
- CuraGen and TopoTarget Initiate Phase Ib/II Clinical Trial With PXD101 and Velcade(R) for Multiple Myeloma
- CuraGen and TopoTarget Initiate Phase II Clinical Trial of PXD101 for T-Cell Lymphoma
 |
 |
User Comments (0)
RSS Feeds